3M wins $250 mil. verdict
This article was originally published in The Gray Sheet
Executive Summary
Litigation over coverage for breast implant claims leaves 29 insurers liable up to the limits of their respective policies, following a Aug. 21 ruling by the Minnesota Supreme Court. "This ruling essentially concludes the eight-year litigation between 3M and these insurers," 3M says. The company was found not guilty of fraud and failure to conduct adequate testing on products in a Texas court in 1999 (1"The Gray Sheet" Feb. 15, 1999, p. 36)...
You may also be interested in...
3M breast implant litigation
Company is found not guilty of fraud and "failure to conduct adequate testing on products" Feb. 10 in Harris County, Texas court. Judge Patrick Mitzell had ruled that plaintiff expert testimony and evidence concerning systemic disease be excluded from the proceedings in a pretrial evidentiary ruling. The verdict marks 3M's 15th victory in breast implant litigation in the past four years
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.